|
|
|
| 
|
|
|
My Recent Searches
|
|
|
|
|
|
|
|
|
$0.00 0.00 (0.00%) as of 4:30 Tue 11/30
|
|
Download |
|
|
| |
| |
| Exchange: |
N/A |
| Security
Type: |
N/A |
| Shares
Out: |
21,850,000 |
| Market
Cap: |
N/A |
| Last
Volume: |
0 |
Avg
Vol: |
0 |
| 52
Week Range: |
$ - $ |
|
| Level
I Sector: |
N/A |
| Level
II Sector: |
N/A |
| Level
III Sector: |
N/A |
|
Member Indexes:
|
Rankings:
|
|
| Insider 3 Months : - |
| Insider 6 Months : - |
| Insider 3/6 Months : - |
|
| Guru Rank Number : - |
| Guru Rank Value : - |
| Guru Occurances : - |
|
|
|
|
|
| |
|
Company Profile Oncorus is a clinical-stage biopharmaceutical company focused on developing viral immunotherapies to transform outcomes for cancer patients. Co.'s primary product candidate ONCR-177, is an intratumorally administered viral immunotherapy based on its oncolytic herpes simplex virus type 1 platform. Co. has developed its Phase 1 clinical trial of ONCR-177 in patients with solid tumors, including breast cancers and cutaneous tumors. Co. is also developing a pipeline of product candidates that utilizes Co.'s second platform, its selectively self-amplifying viral RNA, immunotherapy platform, which aims to enable repeat intravenous, administration of viral immunotherapies to treat cancers.
|
|
|
D/I:
|
|
|
D
is for direct shares.
I is
for indirect shares.
D/I
refers to the Direct or Indirect
shares traded vs. held. |
|
|
|
Forms:
|
|
|
A
Form 4 is a form filed
by an insider to indicate a change
in ownership.
A Form
3 is a form filed by
an insider to indicate an
initial ownership of a security. |
|
|
|
3m +/-:
|
|
|
|
This
represents the company's 3 month
price change. The initial price
is based on the closing price
of the stock on the day the transaction
took place. Purchases & sales
are viewed as long & short
positions respectively.
|
|
|
|
Actions:
|
|
|
| B |
Buy |
| S |
Sell |
| OE |
Option
Exercised |
| A |
Acquired |
| D |
Disposed |
| AB |
Automatic
Buy |
| AS |
Automatic
Sell |
| IO |
Initial
Ownership |
|
|
|
|
Download:
|
|
|
Download only Transactions
Forms. (Default)
Download
only Summary Infomation.
Download
both Transactions and Summary Data
|
|
|
|
|
| |
| |
Summary (Direct Transactions Only)  |
3 Months |
6 Months |
12 Months |
24 Months |
| Total Shares Bought |
0 |
0 |
0 |
49,000 |
| Total Buy Value |
$0 |
$0 |
$0 |
$56,952 |
| Total People Bought |
0 |
0 |
0 |
1 |
| Total Buy Transactions |
0 |
0 |
0 |
7 |
| Total Shares Sold |
0 |
0 |
0 |
551,663 |
| Total Sell Value |
$0 |
$0 |
$0 |
$151,110 |
| Total People Sold |
0 |
0 |
0 |
1 |
| Total Sell Transactions |
0 |
0 |
0 |
11 |
| End Date |
2024-02-08 |
2023-11-07 |
2023-05-09 |
2022-05-09 |
|
| Filer's Name |
Relation Title |
Off-Dir-10% |
Tran. Date |
Form |
Action |
Price |
Mkt Value |
D/I |
Shares |
Holdings |
Rank
|
|
|
| 3m +/- |
|
|
Form |
  Queva Christophe |
CSO and SVP, Research |
• – – |
2021-05-24 |
4 |
OE |
$1.81 |
$64,365 |
D/D |
35,561 |
71,181 |
|
- |
|
| Queva Christophe |
CSO and SVP, Research |
• – – |
2021-04-30 |
4 |
AS |
$15.94 |
$376,123 |
D/D |
(23,555) |
35,620 |
|
- |
|
| Queva Christophe |
CSO and SVP, Research |
• – – |
2021-04-28 |
4 |
AS |
$15.22 |
$273,808 |
D/D |
(17,990) |
59,175 |
|
- |
|
| Queva Christophe |
CSO and SVP, Research |
• – – |
2021-04-27 |
4 |
AS |
$15.00 |
$3,165 |
D/D |
(211) |
77,165 |
|
- |
|
| Queva Christophe |
CSO and SVP, Research |
• – – |
2021-04-26 |
4 |
AS |
$15.00 |
$810 |
D/D |
(54) |
77,376 |
|
- |
|
| Ashburn Theodore |
President and CEO |
• • – |
2021-04-07 |
4 |
OE |
$5.32 |
$24,999 |
D/D |
4,699 |
23,145 |
|
- |
|
| Queva Christophe |
CSO and SVP, Research |
• – – |
2021-04-06 |
4 |
AS |
$15.01 |
$79,553 |
D/D |
(5,300) |
77,430 |
|
- |
|
| Deerfield Capital Lp Et Al |
*Possible Member of 10% Group |
– • • |
2021-02-17 |
4 |
B |
$19.00 |
$5,700,000 |
I/I |
300,000 |
345,167 |
2.25 |
- |
|
| Ashburn Theodore |
President and CEO |
• • – |
2020-12-31 |
4 |
OE |
$1.81 |
$3,439 |
D/D |
1,900 |
18,446 |
|
- |
|
| Mpm Asset Management Llc |
10% Owner |
– – • |
2020-10-06 |
4 |
B |
$15.00 |
$2,606,640 |
I/I |
173,776 |
2,849,453 |
1.5 |
- |
|
| Mpm Asset Management Llc |
10% Owner |
– – • |
2020-10-06 |
4 |
A |
$0.00 |
$0 |
I/I |
2,559,854 |
2,675,677 |
|
- |
|
| Nam Spencer |
Director |
– • – |
2020-10-06 |
4 |
A |
$0.00 |
$0 |
D/D |
1,924 |
1,924 |
|
- |
|
| Mpm Sunstates Gp Managing Member Llc |
10% Owner |
– – • |
2020-10-06 |
4 |
B |
$15.00 |
$2,606,640 |
I/I |
173,776 |
2,849,453 |
1.5 |
- |
|
| Mpm Sunstates Gp Managing Member Llc |
10% Owner |
– – • |
2020-10-06 |
4 |
A |
$0.00 |
$0 |
I/I |
2,559,854 |
2,675,677 |
|
- |
|
| Evnin Luke |
Director |
– • • |
2020-10-06 |
4 |
B |
$15.00 |
$2,268,375 |
I/I |
151,225 |
2,492,843 |
2.25 |
- |
|
| Evnin Luke |
Director |
– • • |
2020-10-06 |
4 |
A |
$0.00 |
$0 |
I/I |
2,225,795 |
2,341,618 |
|
- |
|
| Gadicke Ansbert |
10% Owner |
– – • |
2020-10-06 |
4 |
B |
$15.00 |
$4,875,000 |
I/I |
325,000 |
2,377,025 |
1.5 |
- |
|
| Gadicke Ansbert |
10% Owner |
– – • |
2020-10-06 |
4 |
A |
$0.00 |
$0 |
I/I |
4,785,655 |
2,225,801 |
|
- |
|
| Mpm Oncology Impact Management Lp |
10% Owner |
– – • |
2020-10-06 |
4 |
B |
$15.00 |
$2,268,360 |
D/D |
151,224 |
2,377,025 |
2.45 |
- |
|
| Mpm Oncology Impact Management Lp |
10% Owner |
– – • |
2020-10-06 |
4 |
A |
$0.00 |
$0 |
D/D |
2,225,801 |
2,225,801 |
|
- |
|
| Deerfield Capital Lp Et Al |
*Possible Member of 10% Group |
– • • |
2020-10-06 |
4 |
B |
$15.00 |
$15,000,000 |
I/I |
1,000,000 |
312,282 |
2.25 |
- |
|
| Deerfield Capital Lp Et Al |
*Possible Member of 10% Group |
– • • |
2020-10-06 |
4 |
A |
$0.00 |
$0 |
I/I |
1,848,970 |
202,670 |
|
- |
|
| Mpm Asset Management Llc |
10% Owner |
– – • |
2020-10-01 |
3 |
IO |
$0.00 |
$0 |
I/I |
0 |
115,823 |
|
- |
|
| Evnin Luke |
Director |
– • • |
2020-10-01 |
3 |
IO |
$0.00 |
$0 |
I/I |
0 |
115,823 |
|
- |
|
| Goldberg John Mayer |
SVP, Clinical DevelopmentOffic |
• – – |
2020-10-01 |
3 |
IO |
$0.00 |
$0 |
D/D |
0 |
2,730 |
|
- |
|
54 Records found
|
|
Page 2 of 3 |
|
|
| |
Transaction Code Key: |
Ownership Code Key |
| |
B |
- Buy |
AB |
- Automatic Buy |
D |
- Direct Ownership |
| |
S |
- Sell |
AS |
- Automatic Sell |
I |
- Indirect Ownership |
| |
OE |
- Options Exercised |
A |
- Acquired |
| |
IO |
- Initital Ownership |
D |
- Disposed |
| |
|
|
|
|
|
